ZytoLight ® Bladder Cancer Quadruple Color Probe

The ZytoLight ® Bladder Cancer Quadruple Color Probe is designed to detect CDKN2A (a.k.a. p16) deletions and aneuploidy of chromosomes 3, 7, and 17 in cytology specimens of tumors, e.g., in urine samples from patients with hematuria suspected of having bladder cancer (BC). Moreover, it has been shown that the detection of CDKN2A deletions and/or aneusomies of chromosomes 3, 7, and/or 17 may be used for the surveillance of patients with a history of bladder cancer to early detect possible tumor recurrence.

Probe Maps


Ordering Information

Prod. No.:Tests¹ (Volume):Registration Status²:
5 (50 µl)
20 (200 µl)

Download Information




1 Using 10 μl probe solution per test.
2 In vitro diagnostic medical device according to EU directive 98/79/EC. 
CE IVD only available in certain countries. All other countries research use only! 
Please contact your local dealer for more information.

ISO 9001
ISO 13485
ZytoVision GmbH


For ZytoVision products additional information is available, which is only valid outside the United States of America (USA). With this action you confirm that you have read this legal notice, that you agree with the terms of use, and that you are not intending to use the information provided on this website within USA.

Accept & Continue